Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial

BACKGROUND: The study goal was to determine whether changes in relative cerebral blood volume (rCBV) derived from dynamic susceptibility contrast (DSC) MRI are predictive of overall survival (OS) in patients with recurrent glioblastoma multiforme (GBM) when measured 2, 8, and 16 weeks after treatmen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Schmainda, Kathleen M., Zhang, Zheng, Prah, Melissa, Snyder, Bradley S., Gilbert, Mark R., Sorensen, A. Gregory, Barboriak, Daniel P., Boxerman, Jerrold L.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Neuroimaging
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490871/
https://ncbi.nlm.nih.gov/pubmed/25646027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou364
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky